Bio Green Med Solution (BGMSP) Operating Income (2010 - 2026)

Bio Green Med Solution (BGMSP) has reported Operating Income for 17 consecutive years, with -$418000.0 the latest figure, recorded in Q2 2026.

• On a quarterly basis, Operating Income rose 66.53% year-over-year to -$418000.0 in Q2 2026; TTM through Jun 2026 was -$2.7 million, a 71.08% increase from a year earlier, with the FY2025 full-year figure at -$8.4 million, up 29.8% from the prior year.
• Operating Income was -$418000.0 for Q2 2026 at Bio Green Med Solution, down from -$246000.0 in the prior quarter.
• Over five years, Operating Income peaked at -$246000.0 in Q1 2026 and troughed at -$8.8 million in Q4 2022.
• A 5-year average of -$4.1 million and a median of -$4.3 million in 2024 frame the typical range for Operating Income.
• Across the five-year window, Operating Income slumped 52.36% in 2022 and jumped 94.16% in 2026, its largest moves.
• Over 5 years, Operating Income stood at -$8.8 million in 2022, then jumped by 39.4% to -$5.4 million in 2023, then soared by 65.9% to -$1.8 million in 2024, then soared by 40.81% to -$1.1 million in 2025, then surged by 61.37% to -$418000.0 in 2026.
• The last three Operating Income figures came in at -$418000.0 (Q2 2026), -$246000.0 (Q1 2026), and -$1.1 million (Q4 2025), per Business Quant data.